A Sustained-Release Formulation of L-Dopa (Madopar HBS) in the Treatment of Nocturnal and Early-Morning Disabilities in Parkinson’s Disease

Author Correction: Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson’s disease

Scientific Reports ◽

10.1038/s41598-018-31455-w ◽

2018 ◽

Vol 8 (1) ◽

Cited By ~ 1

Author(s):

Shuchun Chen ◽

Seong-Jin Yu ◽

Yazhou Li ◽

Daniela Lecca ◽

Elliot Glotfelty ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Sustained Release ◽

Rat Model ◽

Post Treatment ◽

Release Formulation ◽

Dopaminergic Neurodegeneration ◽

Long Acting ◽

6 Hydroxydopamine

Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson’s disease

Scientific Reports ◽

10.1038/s41598-018-28449-z ◽

2018 ◽

Vol 8 (1) ◽

Cited By ~ 14

Author(s):

Shuchun Chen ◽

Seong-Jin Yu ◽

Yazhou Li ◽

Daniela Lecca ◽

Elliot Glotfelty ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Sustained Release ◽

Rat Model ◽

Post Treatment ◽

Release Formulation ◽

Dopaminergic Neurodegeneration ◽

Long Acting ◽

6 Hydroxydopamine

Early morning akinesia in Parkinson's disease: Effect of standard carbidopa/levodopa and sustained-release carbidopa/levodopa

Neurology ◽

10.1212/wnl.46.4.1059 ◽

1996 ◽

Vol 46 (4) ◽

pp. 1059-1062 ◽

Cited By ~ 16

Author(s):

R. Pahwa ◽

K. Lyons ◽

D. McGuire ◽

R. Dubinsky ◽

J. P. Hubble ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Sustained Release ◽

Early Morning ◽

Disease Effect

Development of Denticap, a Matrix Based Sustained Release Formulation for Treatment of Toothache, Dental Infection and Other Gum Problem

Current Drug Delivery ◽

10.2174/156720109787846270 ◽

2009 ◽

Vol 6 (2) ◽

pp. 199-207 ◽

Cited By ~ 4

Author(s):

Biswajit Mukherjee ◽

Gopa Roy ◽

Soma Ghosh

Keyword(s):

Sustained Release ◽

Dental Infection ◽

Release Formulation ◽

Exploratory pilot study of exogenous sustained‐release Melatonin on nocturia in Parkinson’s Disease

European Journal of Neurology ◽

10.1111/ene.14774 ◽

2021 ◽

Author(s):

Amit Batla ◽

Sara Simeoni ◽

Tomoyuki Uchiyama ◽

Lorenzo deMin ◽

Joanne Baldwin ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Pilot Study ◽

Sustained Release

Plasma Levels and Negative Chronotropic Effect of Metoprolol following Single Doses of a Conventional and Sustained Release Formulation C. P. Quarterman, M. J. Kendall, R. G. Welling vol. 15, 97?103 (1979)

European Journal of Clinical Pharmacology ◽

10.1007/bf00562065 ◽

1979 ◽

Vol 16 (3) ◽

pp. 219-219

Author(s):

D. A. Piercy ◽

C. P. Quarterman ◽

M. J. Kendall ◽

P. G. Welling

Keyword(s):

Sustained Release ◽

Plasma Levels ◽

Chronotropic Effect ◽

Release Formulation ◽

Negative Chronotropic Effect

Sustained release formulation of an anti-tuberculosis drug based on para-amino salicylic acid-zinc layered hydroxide nanocomposite

Chemistry Central Journal ◽

10.1186/1752-153x-7-72 ◽

2013 ◽

Vol 7 (1) ◽

Cited By ~ 28

Author(s):

Bullo Saifullah ◽

Mohd Zobir Hussein ◽

Samer Hasan Hussein-Al-Ali ◽

Palanisamy Arulselvan ◽

Sharida Fakurazi

Keyword(s):

Salicylic Acid ◽

Sustained Release ◽

Release Formulation ◽

Amino Salicylic Acid ◽

Zinc Layered Hydroxide

P01-45 Twenty-four months efficacy and safety of LB03002, a new sustained release formulation of rhGH, in children with GHD: Extension of a phase III randomized multicentre study

Growth Hormone & IGF Research ◽

10.1016/s1096-6374(12)60124-5 ◽

2012 ◽

Vol 22 ◽

pp. S48

Author(s):

P. Saenger ◽

V. Khadilkar ◽

K.A. Radjuk ◽

E. Bolshova ◽

R. Khadgawat ◽

...

Keyword(s):

Sustained Release ◽

Multicentre Study ◽

Phase Iii ◽

Efficacy And Safety ◽

Release Formulation ◽

Pharmacokinetics of acipimox and of its N-deoxy metabolite following single and repeated oral administration of a sustained release formulation to healthy volunteers

International Journal of Pharmaceutics ◽

10.1016/0378-5173(93)90399-z ◽

1993 ◽

Vol 95 (1-3) ◽

pp. 127-133

Author(s):

C. Efthymiopoulos ◽

D.M.F. Edwards ◽

M. Strolin-Benedetti ◽

F. Ruff ◽

C. Advenier ◽

...

Keyword(s):

Sustained Release ◽

Oral Administration ◽

Healthy Volunteers ◽

Release Formulation ◽

Controlled, eight-hour haemodynamic study of a sustained-release formulation of isosorbide dinitrate in moderate left ventricular failure

European Journal of Clinical Pharmacology ◽

10.1007/bf00542156 ◽

1984 ◽

Vol 27 (3) ◽

pp. 259-263 ◽

Cited By ~ 1

Author(s):

O. Dubourg ◽

P. Gueret ◽

A. Ferrier ◽

J. C. Farcot ◽

M. Terdjman ◽

...

Keyword(s):

Sustained Release ◽

Isosorbide Dinitrate ◽

Left Ventricular ◽

Left Ventricular Failure ◽

Ventricular Failure ◽

Release Formulation ◽

Haemodynamic Study